ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
ASEAN Mosquito-Borne Infections Molecular Testing Market size was valued at USD 41.21 Million in 2021 and is projected to reach USD 74.86 Million by the end of 2030, growing at a CAGR of 5.76% from 2023 to 2030.
There has been a significant focus on the early-stage diagnosis of infection, viral load measurement can be done using the molecular detection method, which is a driving factor supporting the growth of the ASEAN mosquito-borne infections molecular testing market. The ASEAN Mosquito-Borne Infections Molecular Testing Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Okay, so not all insects are villains, right? But some can be total nuisances, and honestly, some are downright dangerous. Think about mosquitoes, for instance. Those buzzing little bloodsuckers can actually spread diseases, which makes them a pretty big deal. We're talking about some scary stuff like Dengue Haemorrhagic Fever (DHF) and chikungunya, spread by those pesky Aedes aegypti and Aedes albopictus mosquitoes, plus Malaria and tons of other yucky illnesses. With all the news about mosquito-borne diseases and how they impact us, we're working hard to fight back. A big part of that is getting better at figuring out what's going on early, and that's where molecular testing is super important. Learn more about mosquito-borne diseases here.
Southeast Asia is a wild mix of everything – how we live, the environment, nature itself, and all the tech we're using. This melting pot is actually helping tiny microbes find new places to thrive! We're talking about booming populations, cities springing up everywhere, big changes in how we farm and eat, and how we use the land. Then there's the stuff we often take for granted, like clean water, sanitation, and how our health systems are battling diseases (and sometimes, unintentionally, creating drug resistance!). This whole region has around 600 million people, but it's a land of contrasts. Look at Laos, still mostly rural with an economy of just USD 890 per person. Then there's Singapore, a buzzing city-state where the average income is around USD 37 500! All this means that catching infections early is a major priority. That's where molecular detection methods come in handy – they're crucial for checking how much virus someone has, and they're really powering the market for mosquito-borne infection testing in the ASEAN region. Check out Laos, for example. They're determined to eliminate malaria by 2030. Even with COVID-19 making things tough, they're testing for malaria more than ever, and it's actually working – cases are going down! They even put out new guidelines at the end of 2020 to actively track, test, and treat every single case. All of this is opening up some pretty exciting doors for companies wanting to get into the molecular testing market for mosquito-borne illnesses in ASEAN.
However, the costs of preventing or controlling mosquito born infectious disease can seem high when compared to the direct public health benefits of such actions. This can be explained as Nucleic acid tests (NATs) that are known as molecular tests are required to be done in a centralized lab location and require expensive equipment and skilled personnel. Thus, the lack of awareness as well as investments are likely to hamper the growth of ASEAN mosquito borne infections molecular testing market.
To Get a Summarized Market Report By Disease Type-
Okay, so back in 2021, dengue was the big player, grabbing a massive 91.20% of the market – that's $33.77 million! And get this, they think it'll keep growing by around 5.89% each year for a while. Now, when it comes to dengue, cases in Southeast Asia shot up by 46% from 2015 to 2019. The good news? Mortality dropped slightly, thankfully, by about 2%. So, what's with all those dengue-spreading mosquitoes in that part of the world? It's complicated! Think fast-growing populations, not enough clean water or good ways to store it, and yucky sewer and garbage problems. Toss in more travel and business, global warming, changes to public health, and some seriously bad city outbreaks, and boom – you've got a real mess. And to top it all off, we're seeing loads of dengue, but not many solid, long-term fixes for mosquito control or effective treatment. Oh, and a heads up – if you think you have dengue, doctors can often spot the virus's RNA in your blood with molecular tests during that first week.
ASEAN Mosquito-Borne Infections Molecular Testing Market, By End-User
• Hospitals And Clinics• Private Commercial Laboratories• Others
To Get a Summarized Market Report By End Users-
In 2021, Hospitals and Clinics were the big kahunas, owning 54.51% of the market, a hefty USD 20.15 Million! And get this – they're predicted to keep expanding by 5.77% annually. These days, hospital higher-ups are mulling over whether opening their own molecular diagnostics lab is the best play and figuring out how to fund all that advanced molecular diagnostic testing. Naturally, they're thinking about boosting revenue and trimming costs. Honestly, the return on investment for molecular tests is looking seriously appealing – much more so than standard clinical chemistry, immunoassays, and culture tests. Not to mention the potential savings from axing a bunch of those costly send-out tests simply by investing in a molecular testing system!
ASEAN Mosquito-Borne Infections Molecular Testing Market, By Geography
In the global market split, Philippines is dominating region-wise while automated is leading according to type. The Philippines is a string of over 7,100 islands situated in South-Eastern Asia between the South China Sea and the Pacific Ocean. The Philippines, being a fertile, tropical and biodiverse land has evolved as a centre for vector-borne diseases burdening the healthcare sector of the country. Main diseases that are largely spreading their presence in the country are Malaria, Dengue, Lymphatic filariasis, Schistosomiasis and Japanese encephalitis.
Key Players
The presence of prominent ASEAN Mosquito-Borne Infections Molecular Testing market players such as InBios International Inc, NovaTec Immundiagnostica GmbH, Abbott Laboratories, Abnova Corporation, Thermo Fisher Scientific Inc., Certest Biotech SL, F. Hoffmann-La Roche Ltd, OriGene Technologies Inc., and Quest Diagnostics.
Key Developments
• September 2018, InBios received 510k marketing clearance from the FDA for its DENV Detect NS1 ELISA kit for many infections disease.
This antigen detection assay provides presumptive diagnosis of dengue virus from serum samples taken from patients within the first seven days of clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. The NS1 kit correctly identified 86.6% of patients confirmed positive for dengue NS1 antigen and 97.8% of negative confirmed patient specimens.
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We really get into the nitty-gritty of the market, using both qualitative and quantitative analysis to slice and dice it every which way! Expect crystal-clear data on the market value (in USD Billion) for each segment and its little sub-segments. And, we'll tell you exactly which regions and segments are going to be the rocket ships, with the most growth and market power. We'll break down each region too, showing you what people are buying and what's making the market tick there – consider it a geographical treasure map! On the competition front, we'll spotlight the top players, their rank in the market, and all the good stuff – new products, partnerships, expansions, and deals from the past five years. You’ll also get detailed company profiles packed with overview, insights, product comparisons, and a classic SWOT analysis. We'll give you the lay of the land now and in the future, factoring in all the recent happenings, opportunities, drivers, hurdles, and limits in both new and established markets. We also go deep into the market's heart with a Porter's five forces analysis, and a clear view of the Value Chain. Finally, we'll spell out the market dynamics for you, pointing out future growth opportunities, and we’ll even throw in 6 months of analyst support after your purchase – we're here to help!
Customization of the Report
• In case of any  please connect with our sales team, who will ensure that your requirements a
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
